Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatal Screening | 18 | 2022 | 102 | 2.740 |
Why?
|
| Cystic Fibrosis | 5 | 2005 | 124 | 0.710 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2021 | 54 | 0.650 |
Why?
|
| Infant, Newborn | 18 | 2022 | 1375 | 0.580 |
Why?
|
| Heptanoates | 1 | 2013 | 3 | 0.400 |
Why?
|
| Tyrosinemias | 1 | 2013 | 20 | 0.390 |
Why?
|
| Genetic Counseling | 2 | 2005 | 16 | 0.300 |
Why?
|
| Program Development | 2 | 2010 | 207 | 0.290 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2010 | 38 | 0.290 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2008 | 9 | 0.290 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2013 | 147 | 0.260 |
Why?
|
| Parents | 3 | 2005 | 395 | 0.260 |
Why?
|
| Genetic Testing | 2 | 2004 | 140 | 0.240 |
Why?
|
| Trypsinogen | 1 | 2004 | 6 | 0.220 |
Why?
|
| Needs Assessment | 1 | 2005 | 203 | 0.210 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 197 | 0.210 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 79 | 0.210 |
Why?
|
| Child Health Services | 1 | 2004 | 64 | 0.200 |
Why?
|
| Massachusetts | 5 | 2021 | 2096 | 0.190 |
Why?
|
| Metabolism, Inborn Errors | 3 | 2011 | 20 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 291 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 489 | 0.170 |
Why?
|
| Program Evaluation | 3 | 2010 | 490 | 0.170 |
Why?
|
| Communication | 1 | 2005 | 587 | 0.170 |
Why?
|
| Health Policy | 1 | 2002 | 195 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 356 | 0.140 |
Why?
|
| Algorithms | 3 | 2010 | 1029 | 0.130 |
Why?
|
| Pilot Projects | 4 | 2011 | 1020 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 1164 | 0.130 |
Why?
|
| Infant | 4 | 2021 | 1664 | 0.120 |
Why?
|
| Humans | 18 | 2022 | 64272 | 0.120 |
Why?
|
| False Positive Reactions | 3 | 2012 | 79 | 0.120 |
Why?
|
| Aftercare | 2 | 2005 | 75 | 0.110 |
Why?
|
| Models, Organizational | 2 | 2005 | 92 | 0.110 |
Why?
|
| Decision Making, Organizational | 2 | 2005 | 26 | 0.100 |
Why?
|
| Genes, T-Cell Receptor | 2 | 2010 | 7 | 0.100 |
Why?
|
| Blood Specimen Collection | 2 | 2010 | 20 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 129 | 0.100 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2010 | 9 | 0.080 |
Why?
|
| Hematologic Tests | 1 | 2010 | 16 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 1105 | 0.080 |
Why?
|
| Health Plan Implementation | 1 | 2010 | 40 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2005 | 771 | 0.080 |
Why?
|
| DNA | 2 | 2010 | 844 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 254 | 0.070 |
Why?
|
| Software | 1 | 2012 | 388 | 0.070 |
Why?
|
| Infant Formula | 1 | 2008 | 12 | 0.070 |
Why?
|
| Carnitine | 1 | 2008 | 20 | 0.070 |
Why?
|
| New England | 2 | 2010 | 269 | 0.070 |
Why?
|
| Point Mutation | 1 | 2008 | 165 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 335 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2010 | 577 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 417 | 0.060 |
Why?
|
| Attitude to Health | 2 | 2005 | 294 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 726 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2008 | 153 | 0.060 |
Why?
|
| Parental Consent | 1 | 2005 | 6 | 0.060 |
Why?
|
| Physician Executives | 1 | 2005 | 28 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1682 | 0.060 |
Why?
|
| Models, Psychological | 1 | 2005 | 99 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 6741 | 0.050 |
Why?
|
| Genetic Carrier Screening | 1 | 2004 | 15 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2003 | 303 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 233 | 0.050 |
Why?
|
| Child Development | 1 | 2003 | 85 | 0.050 |
Why?
|
| Social Support | 1 | 2005 | 376 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 53 | 0.050 |
Why?
|
| Biomarkers | 1 | 2008 | 1431 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 123 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 416 | 0.040 |
Why?
|
| Informed Consent | 1 | 2002 | 141 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 620 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2004 | 428 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 329 | 0.040 |
Why?
|
| Incidence | 1 | 2004 | 1386 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2005 | 711 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2003 | 479 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2021 | 184 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 3725 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2004 | 2605 | 0.030 |
Why?
|
| Male | 4 | 2011 | 30322 | 0.030 |
Why?
|
| Female | 4 | 2011 | 33383 | 0.030 |
Why?
|
| Mutation | 1 | 2004 | 2633 | 0.030 |
Why?
|
| Minnesota | 1 | 2012 | 41 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 53 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 34 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 90 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 194 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2010 | 16 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 41 | 0.020 |
Why?
|
| India | 1 | 2011 | 158 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2010 | 33 | 0.020 |
Why?
|
| Calibration | 1 | 2010 | 67 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 65 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 74 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 58 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 357 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 930 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 498 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 984 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 519 | 0.020 |
Why?
|
| United States | 1 | 2002 | 7923 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 856 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 462 | 0.020 |
Why?
|
| Child | 2 | 2010 | 4583 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2010 | 414 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2482 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 116 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2003 | 172 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 447 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 2019 | 0.010 |
Why?
|
| Hospitalization | 1 | 2003 | 1368 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 3318 | 0.010 |
Why?
|
| Adult | 1 | 2003 | 17136 | 0.000 |
Why?
|